This pilot investigation assessed the effectiveness of a vibrating acoustic device combined with a system of structurally imbedded permanent magnets to increase perfusion in areas of application. The device, a Cyma 1000, delivered five acoustic frequencies 900–1300 Hz chosen for arterial support. The permanent magnet was built into the face of the applicator and oscillated at the same frequencies as the generated acoustic wave. A control group was chosen having normal perfusive ability, a second group was chosen to test the applicator's ability to assist perfusion across a range of pathological conditions. Thermography was used to view perfusion before and after application. Both groups and all cases studied showed application improved perfusion.